Randomized Phase II Study of Docetaxel plus Bevacizumab or Pemetrexed plus Bevacizumab for Elderly Non-Squamous NSCLC (TORG1323)

被引：0
|
作者：
Kozuki, Toshiyuki [1 ]
Nogami, Naoyuki [1 ]
Yamashita, Natsumi [2 ]
Shinkai, Tetsu [3 ]
Shukuya, Takehito [4 ,5 ]
Seki, Nobuhiko [6 ]
Kato, Terufumi [7 ]
Satouchi, Miyako [8 ]
Masuda, Noriyuki [9 ]
Watanabe, Koshiro [10 ]
机构：
[1] Natl Hosp Org, Shikoku Canc Ctr, Dept Thorac Oncol & Med, Matsuyama, Ehime, Japan
[2] Natl Hosp Org, Shikoku Canc Ctr, Clin Res Ctr, Matsuyama, Ehime, Japan
[3] Shonan East Gen Hosp, Dept Internal Med, Chigasaki, Kanagawa, Japan
[4] Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan
[5] Grad Sch Med, Tokyo, Japan
[6] Teikyo Univ, Sch Med, Dept Med Oncol, Tokyo 173, Japan
[7] Kanagawa Cardiovasc & Resp Ctr, Resp Med, Yokohama, Kanagawa, Japan
[8] Hyogo Canc Ctr, Dept Thorac Oncol, Akashi, Hyogo, Japan
[9] Kitasato Univ, Sch Med, Dept Resp Med, Kanagawa, Japan
[10] Thorac Oncol Res Grp, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
elderly; Clinical Trial in Progress; NSCLC; bevacizumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-085
引用
收藏
页码：S666 / S666
页数：1
相关论文
共 50 条
  • [31] Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group
    Kentepozidis, N.
    Kotsakis, A.
    Soultati, A.
    Agelaki, S.
    Christophylakis, Ch.
    Agelidou, M.
    Chelis, L.
    Papakotoulas, P.
    Vamvakas, L.
    Zafiriou, Z.
    Samonis, G.
    Georgoulias, V.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 605 - 612
  • [32] Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group
    N. Kentepozidis
    A. Kotsakis
    A. Soultati
    S. Agelaki
    Ch. Christophylakis
    M. Agelidou
    L. Chelis
    P. Papakotoulas
    L. Vamvakas
    Z. Zafiriou
    G. Samonis
    V. Georgoulias
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 605 - 612
  • [33] PHASE II STUDY OF PEMETREXED (PEM) plus CARBOPLATIN (CB) plus BEVACIZUMAB (BEV) AS FIRST LINE THERAPY FOR NON-SQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC) WITHOUT EGFR MUTATION. CENTRAL JAPAN LUNG STUDY GROUP (CJLSG) 0909 TRIAL.
    Goto, Yasuhiro
    Kimura, Tomoki
    Taniguchi, Hiroyuki
    Iwaki, Mai
    Yamamoto, Masashi
    Suzuki, Ryujiro
    Kondo, Masashi
    Abe, Takashi
    Hataji, Osamu
    Kojima, Eiji
    Yoshida, Norio
    Imaizumi, Kazuyoshi
    Ikeda, Takuya
    Tanikawa, Yoshimasa
    Ando, Takayuki
    Saito, Hiroshi
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S882 - S883
  • [34] Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion
    Tamiya, Motohiro
    Tamiya, Akihiro
    Suzuki, Hidekazu
    Taniguchi, Yoshihiko
    Katayama, Kanako
    Minomo, Shojiro
    Nakao, Keiko
    Takeuchi, Naoko
    Matsuda, Yoshinobu
    Naito, Yujiro
    Shiroyama, Takayuki
    Okamoto, Norio
    Okishio, Kyoichi
    Kumagai, Toru
    Atagi, Shinji
    Imamura, Fumio
    Hirashima, Tomonori
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (04) : 1106 - 1112
  • [35] Pemetrexed (P)/Carboplatin/Bevacizumab (B) Followed by Maintenance P/B in Hispanic Patients with Non-Squamous NSCLC
    Rojas, Leonardo
    Cardona, Andres F.
    Carranza, Hernan
    Vargas, Carlos A.
    Otero, Jorge M.
    Cuello, Mauricio
    Corrales, Luis
    Martin, Claudio
    Arrieta Rodriguez, Oscar
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S661 - S661
  • [36] Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan
    Ahn, Myung-Ju
    Tsai, Chun-Ming
    Hsia, Te-Chun
    Wright, Elaine
    Chang, John Wen-Cheng
    Kim, Heung Tae
    Kim, Joo-Hang
    Kang, Jin Hyoung
    Kim, Sang-We
    Bae, Eun-Jin
    Kang, Mijeong
    Lister, Johanna
    Walzer, Stefan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 : 22 - 33
  • [37] A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer
    Spigel, David R.
    Hainsworth, John D.
    Shipley, Dianna L.
    Ervin, Thomas J.
    Kohler, Peter C.
    Lubiner, Eric T.
    Peyton, James D.
    Waterhouse, David M.
    Burris, Howard A., III
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (01) : 196 - 202
  • [38] PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed plus Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel plus Carboplatin plus Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Zinner, Ralph G.
    Obasaju, Coleman K.
    Spigel, David R.
    Weaver, Robert W.
    Beck, J. Thaddeus
    Waterhouse, David M.
    Modiano, Manuel R.
    Hrinczenko, Borys
    Nikolinakos, Petros G.
    Liu, Jingyi
    Koustenis, Andrew G.
    Winfree, Katherine B.
    Melemed, Symantha A.
    Guba, Susan C.
    Ortuzar, Waldo I.
    Desaiah, Durisala
    Treat, Joseph A.
    Govindan, Ramaswamy
    Ross, Helen J.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (01) : 134 - 142
  • [39] A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases
    Chun, You Jin
    Kim, Seong-Geun
    Lee, Keun-Wook
    Cho, Sang Hee
    Kim, Tae Won
    Baek, Ji Yeon
    Park, Young Suk
    Hong, Soojung
    Chu, Chong Woo
    Beom, Seung-Hoon
    Jung, Minkyu
    Shin, Sang Joon
    Ahn, Joong Bae
    CLINICAL COLORECTAL CANCER, 2020, 19 (03) : E140 - E150
  • [40] A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
    S. Verma
    S. Chitikela
    V. Singh
    S. Khurana
    D. Pushpam
    D. Jain
    S. Kumar
    Y. Gupta
    P. S. Malik
    Medical Oncology, 40
12345